Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 3.61 USD -2.43% Market Closed
Market Cap: 923.1m USD

Wall Street
Price Targets

MRVI Price Targets Summary
Maravai LifeSciences Holdings Inc

Wall Street analysts forecast MRVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRVI is 3.93 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

Lowest
Price Target
2.02 USD
44% Downside
Average
Price Target
3.93 USD
9% Upside
Highest
Price Target
5.25 USD
45% Upside
Maravai LifeSciences Holdings Inc Competitors:
Price Targets
MTD
Mettler-Toledo International Inc
10% Upside
DXRX
Diaceutics PLC
43% Upside
PACB
Pacific Biosciences of California Inc
1% Downside
ILMN
Illumina Inc
3% Downside
300759
Pharmaron Beijing Co Ltd
30% Upside
SHC
Sotera Health Co
16% Upside
CTKB
Cytek Biosciences Inc
21% Upside
ADPT
Adaptive Biotechnologies Corp
38% Upside

Revenue
Forecast

Revenue Estimate
Maravai LifeSciences Holdings Inc

For the last 5 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 13%. The projected CAGR for the next 3 years is -5%.

13%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Maravai LifeSciences Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Maravai LifeSciences Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRVI's stock price target?
Price Target
3.93 USD

According to Wall Street analysts, the average 1-year price target for MRVI is 3.93 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

What is Maravai LifeSciences Holdings Inc's Revenue forecast?
Projected CAGR
-5%

For the last 5 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 13%. The projected CAGR for the next 3 years is -5%.

Back to Top